Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells. - Archive ouverte HAL Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Letters Year : 2014

Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells.

(1) , (2) , (2) , (2) , (3) , (1)
1
2
3

Abstract

We describe the synthesis of a series of new molecules containing phenol and triazoles moieties, compounds which have been evaluated for their ability to inhibit Bax/Bcl-xL interactions in cancer cells, by using BRET assays, and to induce cell death. Several derivatives exhibit a very promising activity, being more potent than the reference compounds acylpyrogallol A and ABT-737. These preliminary results demonstrate that derivatives of this family can be attractive to develop new molecules with potent anticancer activity.
Not file

Dates and versions

hal-01116303 , version 1 (13-02-2015)

Identifiers

Cite

Duc Duy Vo, Fabien Gautier, Sophie Barillé-Nion, Philippe Juin, Nicolas Levoin, et al.. Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells.. Bioorganic and Medicinal Chemistry Letters, 2014, 24 (7), pp.1758-61. ⟨10.1016/j.bmcl.2014.02.035⟩. ⟨hal-01116303⟩
59 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More